MARISSA SPIVEY: Open Payments
NPI 1477332252 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,463 in 110 payments from 35 companies in 2025. Trend: 2023 $367 · 2024 $2,666 · 2025 $2,463
Food & beverage: $2,363Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $368 |
| Merck Sharp & Dohme LLC | 9 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $193 |
| Janssen Biotech, Inc. | 5 | $193 |
| Genentech USA, Inc. | 8 | $164 |
| ABBVIE INC. | 8 | $156 |
| CSL Behring | 3 | $91 |
| Incyte Corporation | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Astellas Pharma US Inc | 3 | $57 |
Products named: KEYTRUDA, KISQALI, FRUZAQLA, ERLEADA, Hizentra, IMFINZI, NINLARO, Polivy.
Industry payments across AL — which companies pay providers there.
